- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Velcade (Bortezomib)
Total 957 results
-
Children's Hospital Medical Center, CincinnatiCompletedAllogeneic Stem Cell Transplantation | Refractory Autoimmune Cytopenia(s)United States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult... and other conditionsUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteWyeth is now a wholly owned subsidiary of Pfizer; Millennium Pharmaceuticals...CompletedMultiple MyelomaUnited States
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
The Methodist Hospital Research InstituteWithdrawnNon-Hodgkin Lymphoma
-
PETHEMA FoundationCompleted
-
Aptium Oncology Research NetworkMillennium Pharmaceuticals, Inc.UnknownNon-small Cell Lung CancerUnited States
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
Singapore General HospitalCompletedAngioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T-cell Lymphoma (Not Otherwise Specified) | Extranodal NK/T-cell Lymphoma Nasal Type | Enteropathy- Type T-cell Lymphoma | Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) | Relapsed ALCL (ALK-1 Positive) Post...Singapore, Malaysia, Korea, Republic of
-
Nantes University HospitalCompleted
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ortho Biotech, Inc.Completed
-
Women and Infants Hospital of Rhode IslandMillennium Pharmaceuticals, Inc.TerminatedCervical CancerUnited States
-
Fondazione EMN Italy OnlusCompleted
-
Masonic Cancer Center, University of MinnesotaMillennium Pharmaceuticals, Inc.TerminatedLymphoproliferative DisorderUnited States
-
Boston VA Research Institute, Inc.Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Medical University of ViennaMedical University InnsbruckCompletedAntibody-mediated Rejection | Late Rejection of Renal TransplantAustria
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non Small Cell Lung
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and... and other collaboratorsCompletedEpstein Barr Virus Infections | Post-transplant Lymphoproliferative Disease | Solid Organ Transplant | Stem Cell Transplant (Bone Marrow Transplant)United States
-
Merck Sharp & Dohme LLCTerminatedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.TerminatedMantle Cell LymphomaUnited States
-
Chinese University of Hong KongShanghai Children's Medical CenterCompletedAcute Lymphoblastic Leukemia, in RelapseHong Kong
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Baylor Research InstituteRecruiting
-
National Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Lymphoma, Mantle CellUnited States
-
Asan Medical CenterUnknownKidney TransplantationKorea, Republic of
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals,...TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
Korean Multiple Myeloma Working PartyJanssen-Cilag Ltd.CompletedMultiple MyelomaKorea, Republic of
-
Masonic Cancer Center, University of MinnesotaMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.TerminatedLeukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Neuroblastoma | WilmsTumorUnited States
-
University Hospital, ToulouseCelgene Corporation; Janssen-Cilag Ltd.Completed
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
Korean Multiple Myeloma Working PartyJanssen-Cilag Ltd.UnknownMultiple MyelomaKorea, Republic of
-
Duke UniversitySpectrum Pharmaceuticals, IncTerminated
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedLymphoma | Mantle Cell Lymphoma | Indolent Lymphoma | SLLUnited States
-
CelgeneTerminated
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States